PLSE
Pulse Biosciences, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$53.24
−2.69%Margins
Gross margin
-21.6%
EBITDA margin
-6738.8%
EBIT margin
-7007.8%
Net margin
-6755.8%
FCF margin
-5180.4%
-80.5%
Return on equity
-69.3%
Return on assets
-78.1%
Return on invested capital
0.01x
Asset turnover
-$61.1M
Cash from operations
$1.42
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026